A Clinical Study on the Evaluation of BD114 for the Treatment HPV-16-Related Cervical HSIL

Clinical trial NCT07170254 · RECRUITING

Trial details

NCT number: NCT07170254
Sponsor: Shanghai BDgene Co., Ltd.
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

High-grade Squamous Intraepithelial Lesions (HSIL)

Start date: 2025-09-01
Primary completion: 2026-12-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.